Acknowledgments
Louise Devlin (TC BioPharm [TCB]) provided clinical trial management and data analysis. Kathryn Hamilton Campbell (TCB) provided quality control for all aspects related to provision of investigational medicinal product. Joseph Anthony Mullen (TCB) managed the manufacture of investigational medicinal product. Áine Prendergast analyzed exploratory blood and bone marrow aspirate samples. Tomasz Zaremba provided clinical oversight of TCB's clinical trials. Markéta Štastná Marková contributed to trial design and provided study patient care.Supplementary material associated with this article can be found, in the online version, at doi: